A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage | MicrobiomeTrials← Back to trialsNCT07770685
A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-10-07Est. Completion: 2030-07-31
Enrollment target: 156 participants Locations- Ophthalmic Consultants of Boston and Boston Eye Surgery & Laser Center, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Primary Open-angle Glaucoma
Mobility refers to a person's purposeful movement through the environment from one place to another and can be conceptua…
Birmingham, United StatesEst. completion May 30, 2019
Neovascular Age-Related Macular Degeneration
This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 m…
Phoenix, United StatesEst. completion Dec 31, 2029
Primary Open Angle Glaucoma
Mobility refers to a person's purposeful movement through the environment from one place to another and can be conceptua…
Birmingham, United StatesEst. completion May 30, 2027